Abstract:The E3 ubiquitin ligase adaptor speckle-type POZ protein (SPOP) is frequently dysregulated in prostate adenocarcinoma (PC), via either somatic mutations or mRNA downregulation, suggesting an important tumour suppressor function. To examine its physiologic role in the prostate epithelium in vivo, we generated mice with prostate-specific biallelic ablation of Spop. These mice exhibited increased prostate mass, prostate epithelial cell proliferation, and expression of c-MYC protein compared to littermate controls, and eventually developed prostatic intraepithelial neoplasia (PIN). We found that SPOPWT can physically interact with c-MYC protein and, upon exogenous expression in vitro, can promote c-MYC ubiquitination and degradation. This effect was attenuated in PC cells by introducing PC-associated SPOP mutants or upon knockdown of SPOP via short-hairpin-RNA, suggesting that SPOP inactivation directly increases c-MYC protein levels. Gene Set Enrichment Analysis revealed enrichment of Myc-induced genes in transcriptomic signatures associated with SPOPMT. Likewise, we observed strong inverse correlation between c-MYC activity and SPOP mRNA levels in two independent PC patient cohorts. The core SPOPMT;MYCHigh transcriptomic response, defined by the overlap between the SPOPMT and c-MYC transcriptomic programmes, was also associated with inferior clinical outcome in human PCs. Finally, the organoid-forming capacity of Spop-null murine prostate cells was more sensitive to c-MYC inhibition than that of Spop-WT cells, suggesting that c-MYC upregulation functionally contributes to the proliferative phenotype of Spop knock-out prostates. Taken together, our data highlight SPOP as an important regulator of luminal epithelial cell proliferation and c-MYC expression in prostate physiology, identify c-MYC as a novel bona fide SPOP substrate, and help explain the frequent inactivation of SPOP in human PC. We propose SPOPMT-induced stabilization of c-MYC protein as a novel mechanism that can increase total c-MYC levels in PC cells, in addition to amplification of c-MYC locus.

SPOP Inhibits BRAF-dependent Tumorigenesis Through Promoting Non-Degradative Ubiquitination of BRAF

TGF- signaling regulates <i>SPOP</i> expression and promotes prostate cancer cell stemness

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression

Intrinsic BET Inhibitor Resistance in SPOP-mutated Prostate Cancer is Mediated by BET Protein Stabilization and AKT–mTORC1 Activation

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

Mutated SPOP E3 Ligase Promotes 17βhsd4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.

Prostate Cancer-Associated Mutation in SPOP Impairs Its Ability to Target Cdc20 for Poly-Ubiquitination and Degradation.

SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Enhanced autophagy and NFE2L2/NRF2 pathway activation in SPOP mutation-driven prostate cancer

Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein

Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis

SPOP Promotes Tumorigenesis by Acting As a Key Regulatory Hub in Kidney Cancer

Identification of SPOP Related Metabolic Pathways in Prostate Cancer.

Prostate Cancer-associated SPOP Mutations Enhance Cancer Cell Survival and Docetaxel Resistance by Upregulating Caprin1-dependent Stress Granule Assembly.

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway

SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer

SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor

TGF-β signaling regulates SPOP expression and promotes prostate cancer cell stemness